These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15301422)

  • 41. Squamous and Glandular Epithelial Tumors of the Cervix: A Pragmatical Review Emphasizing Emerging Issues in Classification, Diagnosis, and Staging.
    Stolnicu S; Soslow RA
    Surg Pathol Clin; 2022 Jun; 15(2):369-388. PubMed ID: 35715166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients.
    Strang P; Stendahl U; Bergström R; Frankendal B; Tribukait B
    Gynecol Oncol; 1991 Oct; 43(1):3-8. PubMed ID: 1959785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
    Horn LC; Raptis G; Nenning H
    Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18.
    Ambros RA; Park JS; Shah KV; Kurman RJ
    Mod Pathol; 1991 Sep; 4(5):586-93. PubMed ID: 1722042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invasive adenocarcinoma of the uterine cervix: MR imaging.
    Torashima M; Yamashita Y; Hatanaka Y; Takahashi M; Miyazaki K; Okamura H
    Comput Med Imaging Graph; 1997; 21(4):253-60. PubMed ID: 9402238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Adenocarcinoma of the uterine cervix--risk factors].
    Stefănescu BI
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):155-60. PubMed ID: 17595861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervical adenocarcinoma identification by testing for chromosomal abnormalities.
    Dittus JL; Dudley BS; Upender M; Endress GA
    Arch Pathol Lab Med; 2013 Dec; 137(12):1829-31. PubMed ID: 24283864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women.
    Das BC; Gopalkrishna V; Das DK; Sharma JK; Singh V; Luthra UK
    Cancer; 1993 Jul; 72(1):147-53. PubMed ID: 8389665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.
    Alfsen GC; Kristensen GB; Skovlund E; Pettersen EO; Abeler VM
    Cancer; 2001 Nov; 92(9):2471-83. PubMed ID: 11745305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
    Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early histological diagnosis of cervical cancer.
    Burghardt E
    Major Probl Obstet Gynecol; 1973; 6():1-401. PubMed ID: 4594637
    [No Abstract]   [Full Text] [Related]  

  • 53. Flow cytometric DNA patterns in cervical carcinoma.
    Strang P; Stendahl U; Frankendal B; Lindgren A
    Acta Radiol Oncol; 1986; 25(4-6):249-54. PubMed ID: 3030052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of diagnostic methods and characteristics of patients operated on for cervical cancer in Lithuania, 1998-2000].
    el-Aawar B
    Medicina (Kaunas); 2002; 38(6):597-610. PubMed ID: 12474666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage Ib.
    Jakobsen A; Bichel P; Kristensen GB; Nyland M
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):969-72. PubMed ID: 3409946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
    Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri.
    Christopherson WM; Nealon N; Gray LA
    Cancer; 1979 Sep; 44(3):975-83. PubMed ID: 476603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does Microinvasive Adenocarcinoma of Cervix Have Poorer Treatment Outcomes than Microinvasive Squamous Cell Carcinoma?
    Ruengkhachorn I; Hanamornroongruang S; Leelaphatanadit C; Sangkarat S
    Asian Pac J Cancer Prev; 2016; 17(8):4013-7. PubMed ID: 27644654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.